Peanut Allergy

Resource Center

Q&As

Expert Q&A

Expert Q&A

Whether the Risks of Peanut Oral Immunotherapy Outweigh the Benefits

05/13/2022

Derek Chu, MD, PhD, from McMaster University in Ontario, Canada, discussed the clinical significance of his new study, which indicates that peanut oral immunotherapy is associated with significantly...

05/13/2022

Research Summaries

FDA Alert

FDA Approves Epinephrine Nasal Spray for Allergic Reactions, Anaphylaxis

08/19/2024

Anthony Calabro, MA

The nasal spray is the first FDA-approved epinephrine product for the treatment of anaphylaxis not to be administered by injection.

08/19/2024

peanut allergy

Adult-Onset Peanut Allergy: What Are the Characteristics?

02/10/2021

Peanut allergies may be a widespread, prevalent occurrence but knowledge gaps remain on peanut allergy in the adult population. In a recent study, researchers examined the prevalence and characteristics of...

02/10/2021

peanut allergy

FDA Panel Recommends Approval of First Therapy for Peanut Allergy

09/16/2019

An FDA advisory committee has recommended the approval of the first therapy for peanut allergies.

09/16/2019

peanut allergy

Oral Immunotherapy Desensitizes Children With Peanut Allergy

11/19/2018

In a recent study, researchers examined the effectiveness of treatment with a peanut-derived investigational biologic oral immunotherapy drug to reduce sensitivity in children and adolescents with severe...

11/19/2018

peanut allergy

Peanut Allergy Unresponsiveness Sustained With Combination Therapy

08/17/2017

Oral immunotherapy may be a possible treatment for food allergies. However, the long-term effects of combined probiotic and oral immunotherapy in individuals with peanut allergy are currently unstudied. ...

08/17/2017

October 2024

Current Issue

October 2024

Volume 64

Issue 9